$HLF (Herbalife Ltd.)

$HLF {{ '2016-07-15T14:24:47+0000' | timeago}} • Announcement

$HLF said it and the Illinois Attorney General also reached a settlement, and $HLF agreed to pay $3MM as part of this separate agreement. With the conclusion of the Illinois investigation, the company is not aware of any active investigations by any other state attorney general.

$PFE {{ '2017-07-24T15:56:36+0000' | timeago}} • Announcement

$PFE's REFLECTIONS B7391003 study, a comparative, confirmatory safety and efficacy study of PF-06439535 versus Avastin, met its primary objective. PF-06439535 is being developed by $PFE as a potential biosimilar to Avastin. Results demonstrate equivalence in objective response rate in patients with advanced non-squamous non-small cell lung cancer.

$GILD {{ '2017-07-24T13:41:56+0000' | timeago}} • Announcement

$GILD announced results from two Phase 3 studies evaluating the efficacy and safety of a fixed-dose combination of bictegravir (BIC) and emtricitabine/tenofovir alafenamide (FTC/TAF) for the treatment of HIV-1 infection in treatment-naïve adults. This regimen has been well tolerated with low rates of discontinuations due to adverse events.

$WBA {{ '2017-07-24T13:07:52+0000' | timeago}} • Announcement

The $WBA management is meeting investors to take questions on general matters. Apart from that, the top brass of the company intends to clarify its participation in the U.S. Health Resources and Services Administration 340B drug pricing program.

$MCK {{ '2017-07-21T16:07:44+0000' | timeago}} • Announcement

Biologics, a unit of healthcare technology firm $MCK, said it will join the limited distribution network of $PBYI to promote the latter’s kinase inhibitor Nerlynx. The formulation is indicated for treatment of adult patients with early-stage HER2 overexpressed/amplified breast cancer.

$REGN {{ '2017-07-21T15:50:38+0000' | timeago}} • Announcement

$REGN and $SNY announced that the European Medicine Agency's Committee for Medicinal Products for Human Use has given a positive opinion for the marketing authorization of Dupixent (dupilumab), recommending its approval in Europe for use in adults with moderate-to-severe atopic dermatitis who are candidates for systemic therapy.

$MRK {{ '2017-07-21T15:21:07+0000' | timeago}} • Announcement

President Donald Trump announced that pharma giants $MRK and $PFE are collaborating with Gorilla Glass manufacturer Corning ($GLW) for manufacturing a new glass (Valor Glass), which is superior and reliable for the delivery of injectable drugs. Corning is planning to initially invest $500MM creating 1,000 jobs at 3 facilities in US.

$MSFT {{ '2017-07-21T14:22:52+0000' | timeago}} • Webcast

$MSFT said the large markets like the US, Germany and Japan performed better than its expectations in 4Q17. To compete with its competitors $GOOGL and $AMZN, Microsoft invested about $3.3Bil in CapEx, which includes the capital leases. This was up sequentially partly due to the deferral of planned datacenter spending from 3Q17 to 4Q17.

$ASH {{ '2017-07-19T20:47:55+0000' | timeago}} • Announcement

$ASH elected Susan Main and Kathleen Wilson-Thompson as new members of its BoD. This  brings the size of the board to 11 directors. Main has served as SVP and CFO of $TDY, and Kathleen is EVP and global chief human resources officer at $WBA.

$GS {{ '2017-07-19T11:22:37+0000' | timeago}} • Webcast

$GS advised a number of important transactions that were announced during 2Q17, including $BCR's $24Bil sale to $BDX. $AMZN's $13.7Bil acquisition of $WFM, and $DFT's $7.6Bil merger with $DLR.

$GILD {{ '2017-07-18T20:14:00+0000' | timeago}} • Announcement

$GILD said the US FDA has approved Vosevi tablets, a single-tablet regimen for the re-treatment of chronic hepatitis C virus (HCV) infection in adults previously treated with or without an NS5A inhibitor-containing regimen. The approval is based on data from the Phase 3 POLARIS-1 and POLARIS-4 studies.

$BAX {{ '2017-07-18T14:01:55+0000' | timeago}} • Announcement

The BoD of $BAX declared a quarterly dividend of $0.16 per share of its common stock. The dividend is payable on Oct 2, 2017, to stockholders of record as of Sept 1, 2017.

$PG {{ '2017-07-17T22:15:27+0000' | timeago}} • Announcement

$PG said it continues to execute on bold productivity initiatives and plans to deliver up to $10Bil over the next five fiscal years. The company recently announced a 3% increase to its quarterly dividend, and expects total dividend payments to shareholders of more than $7Bil in FY17.

$BAX {{ '2017-07-17T20:58:53+0000' | timeago}} • Announcement

$BAX appointed Cathy Smith, EVP and CFO of $TGT, to its BoD, bringing the total number of directors serving the company at this time to 13. Smith now also serves on $BAX's Audit Committee.

$CAR {{ '2017-07-17T13:54:53+0000' | timeago}} • Announcement

Car Rental operator $CAR said it has integrated $AMZN’s voice platform Alexa to allow travelers to book and manage car rental reservations with ease.  Avis is the first car rental company to offer the service.

$GILD {{ '2017-07-13T13:10:29+0000' | timeago}} • Announcement

$GILD said its Marketing Authorization Application for an investigational, once-daily single tablet regimen containing bictegravir and emtricitabine/tenofovir alafenamide, formulations for treatment of HIV-1 infection in adults, has been fully validated. Currently, they are under evaluation by the European Medicines Agency.

$VRTX {{ '2017-07-13T12:31:35+0000' | timeago}} • Announcement

$VRTX announced that the Italian Medicines Agency has agreed to reimburse ORKAMBI (lumacaftor/ivacaftor), the first medicine to treat the underlying cause of cystic fibrosis in people ages 12 and older who have two copies of the F508del mutation. Effective immediately, hundreds of eligible patients in Italy will have access to this medicine.

$PFE {{ '2017-07-13T12:13:49+0000' | timeago}} • Announcement

The FDA has accepted $PFE's filing of supplemental New Drug Application (sNDA) for XELJANZ (tofacitinib citrate), an investigational oral treatment for adult patients with moderately to severely active ulcerative colitis. The FDA has provided an anticipated Prescription Drug User Fee Act action date in March 2018 for the sNDA.

$WBA {{ '2017-07-12T20:41:44+0000' | timeago}} • Announcement

$WBA BoD declared a quarterly dividend of $0.40 per share, up 6.7%. The dividend is payable Sept. 12, 2017 to stockholders of record Aug. 18, 2017, and raised the annual rate from $1.50 per share to $1.60 per share.

$KIM {{ '2017-07-12T15:14:26+0000' | timeago}} • Announcement

$KIM has signed a lease with $TGT for a 48,000-square-foot, small-format store at Westmont Plaza in Haddon Township, New Jersey, set to open in July 2018. The addition of Target is the first step in a larger repositioning of the 173,000-square-foot, open-air center. The store will also offer a CVS Pharmacy and Target’s Order Pickup service.

$AMZN {{ '2017-07-12T13:51:52+0000' | timeago}} • Announcement

$AMZN said on Prime Day 2017, held on July 11, sales surpassed Black Friday and Cyber Monday. The Prime Day 2017 event grew by more than 60% compared to 2016, and sales growth by small businesses and entrepreneurs was even higher. Purchases made on Prime Day 2017 were more than 50% higher than the prior year.

Recent Transcripts

WBA (Walgreens Boots Alliance, Inc.)
Thursday, June 29 2017 - 12:30pm
MCK (McKesson Corporation)
Thursday, May 18 2017 - 9:00pm
TGT (Target Corp.)
Wednesday, May 17 2017 - 12:00pm
VRML (Vermillion, Inc.)
Thursday, May 11 2017 - 12:30pm
WFM (Whole Foods Market, Inc.)
Wednesday, May 10 2017 - 9:00pm
TST (TheStreet, Inc.)
Tuesday, May 9 2017 - 2:30pm
CMRX (Chimerix, Inc.)
Tuesday, May 9 2017 - 12:30pm
REV (Revlon, Inc.)
Friday, May 5 2017 - 1:30pm
HLF (Herbalife Ltd.)
Thursday, May 4 2017 - 9:30pm
REGN (Regeneron Pharmaceuticals, Inc.)
Thursday, May 4 2017 - 12:30pm
ABC (AmerisourceBergen Corporation)
Thursday, May 4 2017 - 12:30pm
KERX (Keryx Biopharmaceuticals Inc.)
Thursday, May 4 2017 - 12:00pm
NUS (Nu Skin Enterprises Inc.)
Wednesday, May 3 2017 - 9:00pm
CLX (The Clorox Company)
Wednesday, May 3 2017 - 5:30pm
GILD (Gilead Sciences Inc.)
Tuesday, May 2 2017 - 8:30pm
PFE (Pfizer Inc.)
Tuesday, May 2 2017 - 2:00pm
CAH (Cardinal Health, Inc.)
Monday, May 1 2017 - 12:30pm
AMZN (Amazon.com, Inc.)
Thursday, April 27 2017 - 9:30pm
VRTX (Vertex Pharmaceuticals Incorporated)
Thursday, April 27 2017 - 8:30pm
BAX (Baxter International Inc.)
Wednesday, April 26 2017 - 12:30pm

AlphaGraphics you may like